JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 23 February 2004. doi:10.1083/jcb1645iti4
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 164, Number 5, 633-633
This Article
Right arrow Full Text (PDF, 652K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Muscle loves company



MyoD- epiblast cells form skeletal muscle (red) if the BMP pathway is blocked.

Future muscle cells recruit more cells to their cause, according to Gerhart et al. on page 739.

The group has isolated a pool of cells from the embryonic epiblast that seems to be committed even before gastrulation to form skeletal muscle. These cells express mRNA for the MyoD transcription factor and form skeletal muscle in vitro if dissociated from other epiblast cells. Muscle formation in vitro requires a switch in expression from E- to N-cadherin, which also occurs as epiblast cells undergo gastrulation in vivo.

If separated from the muscle precursors, cells lacking MyoD retained E-cadherin and did not make muscle. However, when the MyoD- cells were treated with medium from the muscle precursors, they expressed N-cadherin and formed skeletal muscle. BMP-4 was able to block this inductive effect, and inhibition of the BMP receptor in MyoD- cells stimulated muscle formation. This suggests that the muscle precursors secrete a BMP antagonist, possibly Noggin, which recruits more cells to the muscle lineage.

The authors do not yet know whether this recruitment occurs via this mechanism in vivo but plan to test that question soon. They are hopeful that their results may be applied to stem cell–based treatments of degenerative muscle diseases. Injecting pluripotent cells with those that are already programmed to form muscle may produce more muscle than either cell type alone. {blacksquare}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Epiblast cells that express MyoD recruit pluripotent cells to the skeletal muscle lineage
Jacquelyn Gerhart, Christine Neely, Benjamin Stewart, Jordanna Perlman, David Beckmann, Margaretha Wallon, Karen Knudsen, and Mindy George-Weinstein
J. Cell Biol. 2004 164: 739-746. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 652K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents